{
 "edition": "20260903-21",
 "language": "ja",
 "period_start": "2026-09-03T21:00:00+09:00",
 "period_end": "2026-09-04T00:00:00+09:00",
 "page": 2,
 "pages": 2,
 "received_in_period": 105,
 "listed_in_period": 105,
 "description": "2か国・地域のニュースと告知をここでまとめて取得できます：台湾 4ソース 82 件、日本 1ソース 23 件。180分ごとに1号。この時間帯に受信した全ソースの全記事を原文リンク付きで掲載します。",
 "countries": [
  {
   "code": "TW",
   "name": "台湾",
   "items": 82,
   "sources": 4
  },
  {
   "code": "JP",
   "name": "日本",
   "items": 23,
   "sources": 1
  }
 ],
 "number_of_items": 5,
 "items": [
  {
   "id": 2468351,
   "anchor": "n2468351",
   "permalink": "https://ainews.idaeo.ai/180m/20260903-21/index-ja-p2.html#n2468351",
   "title": "亞德客、8月売上高は同期最高。空圧市場の需要拡大局面は2027年まで続く見通し",
   "title_state": "translated",
   "summary": "空圧部品大手の亞德客は、8月売上高が前年同月比43.33％増となり、同期の過去最高を更新した。市場需要の拡大と中国のスマート製造政策が追い風となり、景気拡大は2027年まで続くと見込む。",
   "summary_state": "translated",
   "facts": [],
   "companies": [],
   "published_at": "2026-09-03T20:15:18+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6596588",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2468352,
   "anchor": "n2468352",
   "permalink": "https://ainews.idaeo.ai/180m/20260903-21/index-ja-p2.html#n2468352",
   "title": "安碁資訊、8月売上高は同期最高。AIの急速な発展がサイバーセキュリティー需要を押し上げると期待",
   "title_state": "translated",
   "summary": "安碁資訊の8月売上高は2.2億元で、前年同月比8.21％増となり、同期の過去最高を更新した。AIの発展に伴うサイバーセキュリティー需要の拡大が主因。総経理の吳乙南氏はAIガバナンスの重要性を強調した。",
   "summary_state": "translated",
   "facts": [],
   "companies": [
    "McKinsey & Company"
   ],
   "published_at": "2026-09-03T20:10:45+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6596566",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2468353,
   "anchor": "n2468353",
   "permalink": "https://ainews.idaeo.ai/180m/20260903-21/index-ja-p2.html#n2468353",
   "title": "中信投信、韓国の指数会社AkrosとMOUを締結。台湾ETF市場を共同開拓",
   "title_state": "translated",
   "summary": "中信投信は韓国の指数会社AkrosとMOUを締結した。AIと定量分析技術を組み合わせて革新的なETFを開発し、台湾市場の商品多様化を進め、投資家の資産配分の選択肢を広げる。",
   "summary_state": "translated",
   "facts": [],
   "companies": [
    "Akros Technologies, Inc.",
    "韓国取引所"
   ],
   "published_at": "2026-09-03T20:07:20+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6596569",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2468520,
   "anchor": "n2468520",
   "permalink": "https://ainews.idaeo.ai/180m/20260903-21/index-ja-p2.html#n2468520",
   "title": "09/03「バイオ株の動向」－環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "浩宇生醫9.74%",
     "state": "translated",
     "quote": "浩宇生醫9.74%"
    },
    {
     "text": "藥華藥3.45%",
     "state": "translated",
     "quote": "藥華藥3.45%"
    },
    {
     "text": "漢達2.73%",
     "state": "translated",
     "quote": "漢達2.73%"
    },
    {
     "text": "順藥8.15%",
     "state": "translated",
     "quote": "順藥8.15%"
    },
    {
     "text": "睿生光電6.3%",
     "state": "translated",
     "quote": "睿生光電6.3%"
    },
    {
     "text": "共信-KY5.81%",
     "state": "translated",
     "quote": "共信-KY5.81%"
    }
   ],
   "companies": [
    "安基生技",
    "漢康-KY",
    "泰合",
    "浩宇生醫",
    "藥華藥",
    "漢達",
    "順藥",
    "睿生光電",
    "共信-KY"
   ],
   "published_at": "2026-09-03T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89953&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2468509,
   "anchor": "n2468509",
   "permalink": "https://ainews.idaeo.ai/180m/20260903-21/index-ja-p2.html#n2468509",
   "title": "09/03「バイオ株の動向」－環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "浩宇生醫9.74%",
     "state": "translated",
     "quote": "浩宇生醫9.74%"
    },
    {
     "text": "藥華藥3.45%",
     "state": "translated",
     "quote": "藥華藥3.45%"
    },
    {
     "text": "漢達2.73%",
     "state": "translated",
     "quote": "漢達2.73%"
    },
    {
     "text": "順藥8.15%",
     "state": "translated",
     "quote": "順藥8.15%"
    },
    {
     "text": "睿生光電6.3%",
     "state": "translated",
     "quote": "睿生光電6.3%"
    },
    {
     "text": "共信-KY5.81%",
     "state": "translated",
     "quote": "共信-KY5.81%"
    }
   ],
   "companies": [
    "安基生技",
    "漢康-KY",
    "泰合",
    "浩宇生醫",
    "藥華藥",
    "漢達",
    "順藥",
    "睿生光電",
    "共信-KY"
   ],
   "published_at": "2026-09-03T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89953&range=news",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  }
 ]
}